Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Surgical Technique on Circulating Tumor DNA in Early-Stage Non-Small Cell Lung Cancer

NCT05502523 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05502523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05502523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Surgical Technique on Circulating Tumor DNA in Early-Stage Non-Small Cell Lung Cancer
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2022
Completion date
January 1, 2029
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung non-small cell carcinoma, stage i lung cancer ajcc v8, stage ii lung cancer ajcc v8, stage iii lung cancer ajcc v8